Inovio Stock Volume Indicators Chaikin AD Line

INO
 Stock
  

USD 2.04  0.11  5.70%   

Inovio Pharma volume indicators tool provides the execution environment for running the Chaikin AD Line indicator and other technical functions against Inovio Pharma. Inovio Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volume indicators indicators. As with most other technical indicators, the Chaikin AD Line indicator function is designed to identify and follow existing trends. Inovio Pharma volume indicators are based on Chaikin accumulation (buying pressure) and distribution (selling pressure) factors to determine the likely sustainability of a given price move.

Indicator
The output start index for this execution was zero with a total number of output elements of sixty-one. The Accumulation/Distribution line was developed by Marc Chaikin. It is interpreted by looking at a divergence in the direction of the indicator relative to Inovio Pharma price. If the Accumulation/Distribution Line is trending upward it indicates that the price may follow. If the Accumulation/Distribution Line becomes flat while Inovio Pharma price is still rising (or falling) then it signals a flattening of the price values.
.

Inovio Pharma Technical Analysis Modules

Most technical analysis of Inovio Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Inovio from various momentum indicators to cycle indicators. When you analyze Inovio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Inovio Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Inovio Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Inovio Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Inovio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Inovio Pharma's daily price indicators and compare them against related drivers, such as volume indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Inovio Pharma's intrinsic value. In addition to deriving basic predictive indicators for Inovio Pharma, we also check how macroeconomic factors affect Inovio Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2020 2021 2022 (projected)
PPandE Turnover0.610.120.13
Long Term Debt to Equity0.04050.03740.0384
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inovio Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inovio Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.101.947.14
Details
Intrinsic
Valuation
LowReal ValueHigh
0.244.789.98
Details
Naive
Forecast
LowNext ValueHigh
0.0340291.706.90
Details
8 Analysts
Consensus
LowTarget PriceHigh
6.0013.6235.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharma. Your research has to be compared to or analyzed against Inovio Pharma's peers to derive any actionable benefits. When done correctly, Inovio Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inovio Pharma.

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Options Analysis Now

   

Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module

Inovio Pharma pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inovio Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharma will appreciate offsetting losses from the drop in the long position's value.

Inovio Pharma Pair Trading

Inovio Pharma Pair Trading Analysis

The ability to find closely correlated positions to Inovio Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inovio Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inovio Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inovio Pharma to buy it.
The correlation of Inovio Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inovio Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inovio Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inovio Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please see Risk vs Return Analysis. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for analysis

When running Inovio Pharma price analysis, check to measure Inovio Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharma is operating at the current time. Most of Inovio Pharma's value examination focuses on studying past and present price action to predict the probability of Inovio Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharma's price. Additionally, you may evaluate how the addition of Inovio Pharma to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is Inovio Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharma. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
481.5 M
Quarterly Revenue Growth YOY
30.38
Return On Assets
(0.43) 
Return On Equity
(0.92) 
The market value of Inovio Pharma is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharma's value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharma's market value can be influenced by many factors that don't directly affect Inovio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.